A Study in Myeloproliferative Disorders

Clinical trial NCT01134120 · COMPLETED

Trial details

NCT number: NCT01134120
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Myeloproliferative Disorders Thrombocythemia, Essential Polycythemia Vera Primary Myelofibrosis

Start date: 2010-04-01
Primary completion: 2014-04-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.